News

Charles River generated best-in-class data with Kytopen’s Flowfect™ technology in comparative...
Kytopen awarded competitive phase II SBIR fast-track funding for “Non-Activated Natural Killer...
Kytopen announces the first implementation of its GMP compliant Flowfect Tx™ cellular engineering...
Kytopen announces appointment of industry executive Kevin Gutshall as Chief Commercial Officer ...
Kytopen Announces Launch of Technology Access Program Supported by an Expanded Applications Team
Company Adds Proven Product Development and Commercial Leader as it Accelerates Launch of Flowfect®...
CAMBRIDGE, Mass. — July 11, 2023 — Kytopen, a leading biotechnology company specializing in...
On International Women in Engineering Day, we pay tribute to the exceptional women who have...
Today, we celebrate Kytopen's sixth anniversary, a journey filled with groundbreaking achievements...